Pediatric Multicenter Study of REPEL-CV

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2005 by SyntheMed.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
SyntheMed
ClinicalTrials.gov Identifier:
NCT00116233
First received: June 27, 2005
Last updated: NA
Last verified: June 2005
History: No changes posted

June 27, 2005
June 27, 2005
Not Provided
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Pediatric Multicenter Study of REPEL-CV
Peds. Multicenter Study

This trial will study REPEL-CV for reducing post operative adhesions following cardiovascular (cv) surgery.

- Efficacy at second sternotomy

Interventional
Phase 2
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Adhesions
Device: REPEL-CV
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • Stage sternotomies

Exclusion Criteria:

  • Delayed closure beyond 5 days
Both
up to 1 Year
No
Contact: Eli Pines, Ph.D. 212-460-9488
United States
 
NCT00116233
LMS0104RCV
Not Provided
Not Provided
SyntheMed
Not Provided
Study Director: Eli Pines SyntheMed
SyntheMed
June 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP